The translation regulatory subunit eiF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Csibi, Alfredo ^a,d   Cornille, Karen ^a   Leibovitch, Marie Pierre ^a   Poupon, Anne ^b   Tintignac, Lionel A ^a   Sanchez, Anthony M J ^c   Leibovitch, Serge A ^a  

^a University of Montpellier   (France)

^b UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^c MONTPELLIER SUPAGRO   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; INITIATION FACTOR; INITIATION FACTOR 3F; MAMMALIAN TARGET OF RAPAMYCIN; UNCLASSIFIED DRUG; FBXO32 PROTEIN, MOUSE; INITIATION FACTOR 3; LYSINE; MTORC1 PROTEIN, MOUSE; MUSCLE PROTEIN; PROTEIN SERINE THREONINE KINASE; RPS6KA1 PROTEIN, MOUSE; S6 KINASE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSLATION INITIATION; TRANSLATION REGULATION; ANIMAL; BINDING SITE; CELL CULTURE; CELL DIFFERENTIATION; CELL ENLARGEMENT; CYTOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; MYOBLAST; PROTEIN BINDING; PROTEIN SYNTHESIS; RNA INTERFERENCE; SKELETAL MUSCLE SATELLITE CELL; WESTERN BLOTTING;

MAMMALIA; TOSCANA VIRUS;

ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL ENLARGEMENT; CELLS, CULTURED; EUKARYOTIC INITIATION FACTOR-3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSINE; MALE; MICE; MUSCLE PROTEINS; MUTATION; MYOBLASTS, SKELETAL; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 77749299092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008994     Document Type: Article

References (55)

1. Gingras AC, Raught B, Sonenberg N (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev 15: 807-826.
2. Richardson CJ, Schalm SS, Blenis J (2004) PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol 15: 147-159.
3. Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell 103: 253-262.
4. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
5. Jacinto E, Loewith R, Schmidt A, Linn S, Rüegg MA, et al. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6: 1122-1128.
6. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, et al. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-1302.
7. Wullschleger S, Loewith R, Oppliger W, Hall MN (2005) Molecular organization of target of rapamycin complex 2. J Biol Chem 280: 30697-30704.
8. Avruch J, Belham C, Weng Q, Hara K, Yonezawa K (2001) The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog Mol Subcell Biol 26: 115-154.
9. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
10. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175.
11. Frödin M, Antal TL, Dümmler BA, Jensen CJ, Deak M, et al. (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J 21: 5396-5407.
12. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, et al. (2004) S6K1(-/-)/6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 59-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24: 3112-3124.
13. Glass DJ (2005) Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984.
14. Goldspink DF, Garlick PJ, McNurlan MA (1983) Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem J 210: 89-98.
15. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, et al. (2001a) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019.
16. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S (2002) A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99: 9213-9218.
17. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, et al. (2008) Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 7: 159-72.
18. Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, et al. (2005) Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol 7: 286-294.
19. Bentzinger CF, Romanino K, Cloëtta D, Lin S, Mascarenhas JB, et al. (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8: 411-424.
20. Hofmann K, Bucher P (1998) The PCI domain: a common theme in three multiprotein complexes. Trends Biochem Sci 23: 204-205.
21. Zhou C, Arslan F, Wee S, Krishnan S, Ivanov AR, et al. (2005) PCI proteins eIF3e and eIF3m define distinct translation initiation factor 3 complexes. BMC Biol 3: 14.
22. Valent ST, Gilmartin M, Mott C, Falkard B, Goff SP (2009) Inhibition of HIV-1 replication by eIF3f. Proc Natl Acad Sci USA 106: 4071-4078.
23. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, et al. (2006) Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 25: 4923-4936.
24. Csibi A, Tintignac LA, Leibovitch MP, Leibovitch SA (2008) eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy. Cell Cycle 7: 1698-1701.
25. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, et al. (2008) The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 27: 1266-1276.
26. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, et al. (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB 18: 39-51.
27. Holz MK, Ballif BA, Gygi SP, Blenis J (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123: 569-580.
28. Harris TE, Chi A, Shabanowitz J, Hunt DF, Rhoads RE, et al. (2006) mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J 25: 1659-1668.
29. Csibi A, Leibovitch MP, Cornille K, Tintignac LA, Leibovitch SA (2009) MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines. J Biol Chem 284: 4413-4421.
30. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001b) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
31. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. U. S. A. 98: 14440-14445.
32. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
33. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, et al. (2009) Inhibition of Atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PloS ONE 4: e4973.
34. Erbay E, Chen J (2001) The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem 276: 36079-36082.
35. Yoon MS, Chen J (2008) PLD regulates myoblast differentiation through the mTOR-IGF2 pathway. J Cell Sci 121: 282-289.
36. Hara K, Maruki Y, Long X, Yoshino K, Hidayat S, et al. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110: 177-189.
37. Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, et al. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J biol Chem 278: 15461-15465.
38. Schalm SS, Blenis J (2002) Identification of a conserved motif required for mTOR signaling. Current Biol 12: 632-639.
39. Sanches M, Alves B, Zanchin N, Guimaraes B (2007) The Crystal Structure of the Human Mov34 MPN Domain Reveals a Metal-free Dimer. J Mol Biol 370: 846-855.
40. Pons J, Labesse G (2009) @TOME-2: a new pipeline for comparative modeling of protein-ligand complexes. Nucleic Acid Res 37: 485-491.
41. Sonenberg N, Hershey JWB, Mathews M (2000) Translational control of gene expression. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. 1020 p.
42. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, et al. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282: 14056-14064.
43. Shi J, Hershey JWB, Nelson MA (2009) Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis. FEBS Lett 583: 971-977.
44. Miyamoto S, Patel P, Hershey JWB (2005) Changes in ribosomal binding activity of eIF3 correlate with increased translation rates during activation of T lymphocytes. J Biol Chem 280: 28251-28264.
45. Park IH, Chen J (2005) Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J Biol Chem 280: 32009-32017.
46. Kip2. J Biol Chem 275: 18767-18776.
47. Eswar N, Eramian D, Webb B, Shen M, Sali A (2008) "Protein structure modeling with MODELLER." Methods Mol Biol 426: 145-159.
48. Altschul S, Madden T, Schäffer A, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 25: 3389-3402.
49. Zhou H, Zhou Y (2005) "Fold recognition by combining sequence profiles derived from evolution and from depth-dependent structural alignment of fragments." Proteins vol58: 321-328.
50. Pons J, Labesse G (2009) "@TOME-2: a new pipeline for comparative modeling of protein-ligand complexes." Nucleic Acid Res 37: 485-491.
51. Schwieters C, Kuszewski J, Clore G (2006) Using Xplor-NIH for NMR molecular structure determination. Progr. NMR Spectroscopy 48: 47-62.
52. DeLano W (2008) The PyMOL Molecular Graphics System. Palo Alto, CA, USA: DeLano Scientific LLC.
53. Coeytaux K, Poupon A (2005) "Prediction of unfolded segments in a protein sequence based on amino acid composition." Bioinformatics 21: 1891-1900.
54. Wiederstein M, Sippl M (2007) "ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins." Nucleic Acid Res 35: 407-410.
55. Lüthy R, Bowie J, Eisenberg D (1992) "Assessment of protein models with three-dimensional profiles." Nature 356: 83-85.